8-K
Jupiter Neurosciences, Inc. Amends Bylaws to Update Quorum Requirements
8-K
Jupiter Neurosciences Receives Nasdaq Delisting Notice but Regains Minimum Bid Price Compliance
8-K
Jupiter Neurosciences, Inc. Announces Debt Forgiveness by Executive Officers and Directors
8-K
Jupiter Neurosciences, Inc. Closes $2.0 Million Registered Direct Offering to Regain Nasdaq Compliance
8-K
Jupiter Neurosciences Announces Pricing of $2.0 Million Registered Direct Offering
8-K
Jupiter Neurosciences, Inc. Announces 1-for-75 Reverse Stock Split
